INSIDER
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

Robinhood Chain…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
Search

All disclosures

Every ingested record across SEC Form 4, 13F, House PTRs and Robinhood Chain, searchable by ticker, name or wallet address.

Results

Data sources
SEC Form 43h ago
House PTR3h ago
SEC 13F3h ago
Robinhood Chain3h ago

Results

82,042 records
Side
allbuysell
Score
any≥ 30≥ 50≥ 70
Sort
Newest disclosedNewest executedInsider ScoreValue
Include
grants & admin
ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
9
FL
Freemen-Bosworth LaurenEVP/Gen Counsel & Corp Sec
PBIPITNEY BOWES INC /DE/
Grant or award
A—
19.7K sh
Mar 3, 2026Mar 5, 2026
Page 1474 of 2052
← PrevNext →
traded Mar 3, 2026
+2d
SEC Form 4

Evidence

9
SD
Silva Effie DSVP, General Counsel & Secy
FDPDEL MONTE CORP
Option exercise
M—
2,109 sh
Mar 3, 2026Mar 5, 2026
traded Mar 3, 2026
+2dSEC Form 4

Evidence

9
OT
Osben TeoChief Accounting Officer
RALRalliant Corp
Tax withholding
F$32K
700 sh
Mar 3, 2026Mar 5, 2026
traded Mar 3, 2026
+2dSEC Form 4

Evidence

9
WV
Walter Eric V.Chief Financial Officer
BOOMDMC Global Inc.
Grant or award
A—
54.3K sh
Mar 3, 2026Mar 5, 2026
traded Mar 3, 2026
+2dSEC Form 4

Evidence

9
WL
Wu LeiDirector, Chief Executive Officer, 10% Owner
GCTGigaCloud Technology Inc
Open-market sale · 10b5-1 plan
SELL$396K
9,090 sh
Mar 4, 2026Mar 5, 2026
traded Mar 4, 2026
+1dSEC Form 4

Evidence

9
WL
Wu LeiDirector, Chief Executive Officer, 10% Owner
GCTGigaCloud Technology Inc
Open-market sale · 10b5-1 plan
SELL$660K
15.9K sh
Mar 3, 2026Mar 5, 2026
traded Mar 3, 2026
+2dSEC Form 4

Evidence

9
SS
Sanfrey Jeffrey ScottChief Operating Officer
BLBDBlue Bird Corp
Option exercise
M—
5,192 sh
Mar 4, 2026Mar 5, 2026
traded Mar 4, 2026
+1dSEC Form 4

Evidence

9
AD
Anderson Woodrow DChief Accounting Officer
INDVIndivior Pharmaceuticals, Inc.
Option exercise
M—
5,946 sh
Mar 3, 2026Mar 5, 2026
traded Mar 3, 2026
+2dSEC Form 4

Evidence

9
PB
PAEPER HOLLY BethDirector
LFUSLITTELFUSE INC /DE
Grant or award
A—
72 sh
Mar 4, 2026Mar 5, 2026
traded Mar 4, 2026
+1dSEC Form 4

Evidence

9
CH
Conway Patrick HughDirector
PACSPACS Group, Inc.
Grant or award
A—
3,497 sh
Mar 4, 2026Mar 5, 2026
traded Mar 4, 2026
+1dSEC Form 4

Evidence

9
HM
Hafner Patrick MEVP, Pres Outback Steakhouse
BLMNBloomin' Brands, Inc.
Tax withholding
F$13K
1,973 sh
Mar 3, 2026Mar 5, 2026
traded Mar 3, 2026
+2dSEC Form 4

Evidence

9
VM
Vicente MonicaSVP, Chief Financial Officer
FDPDEL MONTE CORP
Option exercise
M—
178 sh
Mar 3, 2026Mar 5, 2026
traded Mar 3, 2026
+2dSEC Form 4

Evidence

9
PD
Pfeiffer DeborahEVP & Pres, Presort Services
PBIPITNEY BOWES INC /DE/
Grant or award
A—
27.0K sh
Mar 3, 2026Mar 5, 2026
traded Mar 3, 2026
+2dSEC Form 4

Evidence

9
PR
Preblick RyanChief Financial Officer
INDVIndivior Pharmaceuticals, Inc.
Option exercise
M—
113.5K sh
Mar 3, 2026Mar 5, 2026
traded Mar 3, 2026
+2dSEC Form 4

Evidence

9
BB
Ben Arye BarakGeneral Counsel
NVCRNovoCure Ltd
Grant or award
A—
73.3K sh
Mar 3, 2026Mar 5, 2026
traded Mar 3, 2026
+2dSEC Form 4

Evidence

8
WC
Werner Edward CooperChief Financial Officer
FFIVF5, INC.
Open-market sale · 10b5-1 plan
SELL$60K
209 sh
Mar 4, 2026Mar 5, 2026
traded Mar 4, 2026
+1dSEC Form 4

Evidence

8
WK
Williams Robert KirkChief People & Admin Officer
DFINDonnelley Financial Solutions, Inc.
Tax withholding
F$51K
954 sh
Mar 4, 2026Mar 5, 2026
traded Mar 4, 2026
+1dSEC Form 4

Evidence

8
KK
Kalia KumudChief Information Officer
GHGuardant Health, Inc.
Option exercise
M$74K
1,000 sh
Mar 4, 2026Mar 5, 2026
traded Mar 4, 2026
+1dSEC Form 4

Evidence

7
MP
McNamara PeterChief Scientific Officer
TECXTectonic Therapeutic, Inc.
Grant or award · 10b5-1 plan
A—
23.0K sh
Mar 4, 2026Mar 5, 2026
traded Mar 4, 2026
+1dSEC Form 4

Evidence

6
SA
Steenberge Michael AnthonyChief Accounting Officer
PARPAR TECHNOLOGY CORP
Open-market sale · 10b5-1 plan
SELL$11K
582 sh
Mar 4, 2026Mar 5, 2026
traded Mar 4, 2026
+1dSEC Form 4

Evidence

6
WL
Wu LeiDirector, Chief Executive Officer, 10% Owner
GCTGigaCloud Technology Inc
Open-market sale · 10b5-1 plan
SELL$72K
1,600 sh
Mar 4, 2026Mar 5, 2026
traded Mar 4, 2026
+1dSEC Form 4

Evidence

6
MP
McNamara PeterChief Scientific Officer
TECXTectonic Therapeutic, Inc.
Open-market sale · 10b5-1 plan
SELL$41K
1,650 sh
Mar 4, 2026Mar 5, 2026
traded Mar 4, 2026
+1dSEC Form 4

Evidence

6
WL
Wu LeiDirector, Chief Executive Officer, 10% Owner
GCTGigaCloud Technology Inc
Open-market sale · 10b5-1 plan
SELL$128K
2,937 sh
Mar 5, 2026Mar 5, 2026
traded Mar 5, 2026
+0dSEC Form 4

Evidence

5
KK
Kalia KumudChief Information Officer
GHGuardant Health, Inc.
Option exercise
M—
1,000 sh
Mar 4, 2026Mar 5, 2026
traded Mar 4, 2026
+1dSEC Form 4

Evidence

5
SD
Silva Effie DSVP, General Counsel & Secy
FDPDEL MONTE CORP
Option exercise
M—
151 sh
Mar 3, 2026Mar 5, 2026
traded Mar 3, 2026
+2dSEC Form 4

Evidence

5
WC
Werner Edward CooperChief Financial Officer
FFIVF5, INC.
Open-market sale · 10b5-1 plan
SELL$23K
80 sh
Mar 4, 2026Mar 5, 2026
traded Mar 4, 2026
+1dSEC Form 4

Evidence

5
WC
Werner Edward CooperChief Financial Officer
FFIVF5, INC.
Open-market sale · 10b5-1 plan
SELL$11K
40 sh
Mar 4, 2026Mar 5, 2026
traded Mar 4, 2026
+1dSEC Form 4

Evidence

5
KK
Kalia KumudChief Information Officer
GHGuardant Health, Inc.
Option exercise
M—
2,119 sh
Mar 4, 2026Mar 5, 2026
traded Mar 4, 2026
+1dSEC Form 4

Evidence

5
KK
Kalia KumudChief Information Officer
GHGuardant Health, Inc.
Option exercise
M—
10.0K sh
Mar 4, 2026Mar 5, 2026
traded Mar 4, 2026
+1dSEC Form 4

Evidence

5
WC
Werner Edward CooperChief Financial Officer
FFIVF5, INC.
Open-market sale · 10b5-1 plan
SELL$23K
80 sh
Mar 4, 2026Mar 5, 2026
traded Mar 4, 2026
+1dSEC Form 4

Evidence

5
RR
Renninger RobertCHIEF FINANCIAL OFFICER
LONALeonaBio, Inc.
Option exercise
M—
3,900 sh
Mar 3, 2026Mar 5, 2026
traded Mar 3, 2026
+2dSEC Form 4

Evidence

2
FK
Feeley KevinCHIEF FINANCIAL OFFICER
WGSGeneDx Holdings Corp.
Grant or award
A—
10.9K sh
Mar 3, 2026Mar 5, 2026
traded Mar 3, 2026
+2dSEC Form 4

Evidence

2
DB
Dechairo BryanChief Operating Officer
WGSGeneDx Holdings Corp.
Grant or award
A—
10.4K sh
Mar 3, 2026Mar 5, 2026
traded Mar 3, 2026
+2dSEC Form 4

Evidence

1
HM
Hopman MarkChief Commercial Officer
BBNXBeta Bionics, Inc.
Open-market sale · 10b5-1 plan
SELL$4,084
353 sh
Mar 4, 2026Mar 5, 2026
traded Mar 4, 2026
+1dSEC Form 4

Evidence

0
BM
Bick Karen M.SVP - Chief People Officer
RALRalliant Corp
Tax withholding · 10b5-1 plan
F$34K
733 sh
Mar 4, 2026Mar 5, 2026
traded Mar 4, 2026
+1dSEC Form 4

Evidence

0
RR
Ribeiro RamiroChief Medical Officer
EYPTEyePoint, Inc.
Option exercise · 10b5-1 plan
M$20K
2,438 sh
Mar 4, 2026Mar 5, 2026
traded Mar 4, 2026
+1dSEC Form 4

Evidence

0
RR
Ribeiro RamiroChief Medical Officer
EYPTEyePoint, Inc.
Option exercise · 10b5-1 plan
M—
2,438 sh
Mar 4, 2026Mar 5, 2026
traded Mar 4, 2026
+1dSEC Form 4

Evidence

0
BM
Bick Karen M.SVP - Chief People Officer
RALRalliant Corp
Tax withholding · 10b5-1 plan
F$39K
841 sh
Mar 3, 2026Mar 5, 2026
traded Mar 3, 2026
+2dSEC Form 4

Evidence

0
MP
McNamara PeterChief Scientific Officer
TECXTectonic Therapeutic, Inc.
Grant or award · 10b5-1 plan
A—
21.0K sh
Mar 4, 2026Mar 5, 2026
traded Mar 4, 2026
+1dSEC Form 4

Evidence

65
MF
Musser ForySenior VP, Development
VGVenture Global, Inc.
Open-market sale
SELL$10.90M
1.00M sh
Mar 4, 2026Mar 4, 2026
traded Mar 4, 2026
+0dSEC Form 4

Evidence